Respiratory Section, Hvidovre Hospital, Hvidovre, Denmark.
N Engl J Med. 2011 Sep 29;365(13):1184-92. doi: 10.1056/NEJMoa1105482. Epub 2011 Sep 26.
A key feature of chronic obstructive pulmonary disease (COPD) is an accelerated rate of decline in forced expiratory volume in 1 second (FEV(1)), but data on the variability and determinants of this change in patients who have established disease are scarce.
We analyzed the changes in FEV(1) after administration of a bronchodilator over a 3-year period in 2163 patients. A random-coefficient model was used to evaluate possible predictors of both FEV(1) levels and their changes over time.
The mean (±SE) rate of change in FEV(1) was a decline of 33±2 ml per year, with significant variation among the patients studied. The between-patient standard deviation for the rate of decline was 59 ml per year. Over the 3-year study period, 38% of patients had an estimated decline in FEV(1) of more than 40 ml per year, 31% had a decline of 21 to 40 ml per year, 23% had a change in FEV(1) that ranged from a decrease of 20 ml per year to an increase of 20 ml per year, and 8% had an increase of more than 20 ml per year. The mean rate of decline in FEV(1) was 21±4 ml per year greater in current smokers than in current nonsmokers, 13±4 ml per year greater in patients with emphysema than in those without emphysema, and 17±4 ml per year greater in patients with bronchodilator reversibility than in those without reversibility.
The rate of change in FEV(1) among patients with COPD is highly variable, with increased rates of decline among current smokers, patients with bronchodilator reversibility, and patients with emphysema.
慢性阻塞性肺疾病(COPD)的一个主要特征是 1 秒用力呼气量(FEV1)的下降速度加快,但关于已确诊疾病患者中这种变化的可变性和决定因素的数据很少。
我们分析了 2163 例患者在 3 年内使用支气管扩张剂后 FEV1 的变化。使用随机系数模型来评估 FEV1 水平及其随时间变化的可能预测因素。
FEV1 的平均(±SE)变化率为每年下降 33±2ml,患者之间存在显著差异。患者之间每年下降率的标准差为 59ml。在 3 年的研究期间,38%的患者预计 FEV1 每年下降超过 40ml,31%的患者每年下降 21-40ml,23%的患者 FEV1 变化范围为每年下降 20ml 至增加 20ml,8%的患者每年增加超过 20ml。与当前不吸烟者相比,当前吸烟者的 FEV1 年平均下降率高 21±4ml,肺气肿患者比无肺气肿患者高 13±4ml,支气管扩张剂可逆性患者比无可逆性患者高 17±4ml。
COPD 患者的 FEV1 变化率差异很大,吸烟者、支气管扩张剂可逆性患者和肺气肿患者的下降率更高。